Treats wound sepsis. NDA 18578, held by Dr Reddys. Silver Sulfadiazine.
As of Nov 14, 2026, NDA 18578 (Ssd, Ssd Af), held by Dr Reddys, was first approved by FDA on Feb 25, 1982, with 13 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 1982 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Ssd1% · cream;topical | Silver Sulfadiazine | RxReference drug |
| Ssd Af1% · cream;topical | Silver Sulfadiazine | Discontinued |
| Apr 21, 2014 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| May 24, 2000 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Jan 12, 1999 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Jan 11, 1995 | Supplement 11Manufacturing · Standard review | Approved | None posted |
| Aug 3, 1990 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Jul 11, 1990 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| Jul 11, 1990 | Supplement 6Labeling | Approved | None posted |
| Mar 15, 1989 | Supplement 7Manufacturing · Standard review | Approved | None posted |
| Dec 10, 1985 | Supplement 5Labeling | Approved | None posted |
| Jan 29, 1985 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Mar 16, 1984 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Aug 19, 1983 | Supplement 3Labeling | Approved | None posted |
| May 12, 1983 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Feb 25, 1982 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters